Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Nasopharyngeal Neoplasms 1Lymphoma, Primary Effusion 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

Doxorubicin 10Zidovudine 9Vincristine 7Bleomycin 7Nivolumab 6Liposomes 5Interferon alpha-2 5Etoposide 5tecogalan 4pembrolizumab 4liposomal doxorubicin 4Valganciclovir 4Specimen Handling 4Semaxinib 4Paclitaxel 4Nelfinavir 4Magnetic Resonance Spectroscopy 4pomalidomide 3Ritonavir 3Filgrastim 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2sargramostim 2interferon alfa-n1 2Propranolol 2Indinavir 2Docetaxel 2Didanosine 2Daunorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × fialuridine × Clear all
NCT00982449 2018-09-17

124I-FIAU Imaging in EBV and KSHV Associated Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Completed
12 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Sarcoma, Kaposi, Stomach Neoplasms, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡